What is the global market size of Infectious Disease Diagnostics Market?

The Global Infectious Disease Diagnostics Market was valued at USD 27.89 Billion in 2021, and it is expected to reach a value of USD 44.46 Billion by 2028, at a CAGR of 6.89% over the forecast period (2022 - 2028).

Who are the key vendors in the Global Infectious Disease Diagnostics Market?

The Infectious Disease Diagnostics Market is highly fragmented, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the Infectious Disease Diagnostics Market are Veracyte Inc., Abbott Laboratories Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche Ltd, and Becton, Dickinson, and Company.'Abbott Laboratories (US)','F. Hoffmann-La Roche Ltd (Switzerland)','BioMérieux SA (France)','Thermo Fisher Scientific Inc. (US)','Danaher Corporation (US)','Quidel Corporation(US)','Hologic, Inc. (US)','Siemens Healthineers AG (Germany)','Becton, Dickinson, and Company (US)','PerkinElmer Inc. (US)','QIAGEN (Netherlands)','Grifols S.A. (Spain)','DiaSorin S.p.A (Italy)','Bio-Rad Laboratories, Inc. (US)','Sysmex Corporation (Japan)','Ortho Clinical Diagnostics (US)','Luminex Corporation (US)','Meridian Bioscience (US)','Danaher Corporation (US)','Mesa Biotech (US)'

What is the key driver of Global Infectious Disease Diagnostics Market?

The prevalence of infectious diseases in developed and developing regions will have a positive impact on the infectious disease diagnostics market. The increasing number of prescriptions for infectious disease diagnostic tests is attributable to the diagnosis and management of such diseases. These factors, combined with the growing trend toward preventive medicine, are expected to drive demand for infectious disease diagnostics over the forecast period.

What is the key market trend for Global Infectious Disease Diagnostics Market?

Despite the enormous efforts put into infectious disease management, the development of low-cost, accurate, and sensitive POC products is in high demand. Nanotechnology has paved the way for widespread use in the healthcare industry. Several players have emphasized the introduction of POC platforms based on nanoparticles and Nanodevices.

Which region accounted for the largest share in Global Infectious Disease Diagnostics Market?

North America held the largest share of the global infectious disease diagnostics market in 2021. The growth of the North American infectious disease diagnostics market can be attributed to the highly developed healthcare systems in the United States and Canada, the presence of many leading national clinical laboratories, and the ease of access to technologically advanced instruments. Within North America, the United States has held a large market share. The increasing prevalence of infectious diseases, high healthcare expenditure, and increased population awareness about the availability of treatment devices are the major factors driving the Infectious Disease Diagnostics Market growth.

Infectious Disease Diagnostics Companies

Infectious Disease Diagnostics Market Competitive Landscape

Infectious Disease Diagnostics Market Top Player’s Company Profiles

F. Hoffmann-La Roche Ltd. (Switzerland)
Abbott (US)
bioMérieux (France)
Siemens Healthineers AG (Germany)
Danaher (US)
Thermo Fisher Scientific Inc. (US)
Hologic, Inc. (US)
Becton, Dickinson and Company (US)
Revvity (US)
Qiagen (Netherlands)
Seegene Inc. (South Korea)
QuidelOrtho Corporation (US)
Grifols, S.A. (Spain)
DiaSorin S.p.A. (Italy)
Bio-Rad Laboratories, Inc. (US)
Sysmex Corporation (Japan)
OraSure Technologies (US)
Co-Diagnostics, Inc. (US)
Trinity Biotech (Ireland)
Genetic Signatures Ltd. (Australia)
Epitope Diagnostics, Inc. (US)
Trivitron Healthcare (India)
ELITech Group (France)
Meril Life Sciences Pvt. Ltd. (India)
InBios International, Inc. (US)
Uniogen Oy (Finland)
Vela Diagnostics (Singapore)

Infectious Disease Diagnostics Market

FAQs

Global Infectious Disease Diagnostics Market size was valued at USD 21.20 billion in 2022 and is poised to grow from USD 22.94 billion in 2023 to USD 43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period (2024-2031).

The competitive scenario of the infectious disease diagnostics market is characterized by established global players, emerging companies and local organizations all contributing to the growth of the industry by innovative a manufacture, partnerships and expansion of strategies. Major manufacturers such as Abbott Laboratories, Roche Diagnostics, Becton, Dickinson & Company (BD), and Biomeriex are market leaders, offering a range of diagnostic solutions from molecular diagnostics to point-of-care testing (POCT). These companies have strengthened their market positions through extensive divisions, strong R&D investments and global distribution networks. 'F. Hoffmann-La Roche Ltd. (Switzerland) ', 'Abbott (US) ', 'bioMérieux (France) ', 'Siemens Healthineers AG (Germany) ', 'Danaher (US) ', 'Thermo Fisher Scientific Inc. (US) ', 'Hologic, Inc. (US) ', 'Becton, Dickinson and Company (US) ', 'Revvity (US) ', 'Qiagen (Netherlands) ', 'Seegene Inc. (South Korea) ', 'QuidelOrtho Corporation (US) ', 'Grifols, S.A. (Spain) ', 'DiaSorin S.p.A. (Italy) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Sysmex Corporation (Japan) ', 'OraSure Technologies (US) ', 'Co-Diagnostics, Inc. (US) ', 'Trinity Biotech (Ireland) ', 'Genetic Signatures Ltd. (Australia) ', 'Epitope Diagnostics, Inc. (US) ', 'Trivitron Healthcare (India) ', 'ELITech Group (France) ', 'Meril Life Sciences Pvt. Ltd. (India) ', 'InBios International, Inc. (US) ', 'Uniogen Oy (Finland) ', 'Vela Diagnostics (Singapore)'

The rise in infectious sicknesses which includes HIV, tuberculosis, hepatitis. COVID-19 is driving the demand for advanced diagnostics globally. These sicknesses require accurate, early diagnosis for powerful treatment, and wearable injectors, incorporated with diagnostic technologies, provide progressive solutions. Additionally, the increasing attention on disorder surveillance and outbreak monitoring has amplified the need for on-hand and speedy diagnostics, assisting marketplace expansion.

Increase in Point-of-Care Testing (POCT): A major trend in the infectious disease diagnostics market is the rise of POCT. Changes in the decentralization of health care delivery and rapid on-demand analysis have led to the adoption of easy-to-use portable diagnostic kits. This trend does not appear to give rise to not only increases patient attendance but also reduces stress on hospitals by allowing outpatient testing.

North America region in the infectious disease diagnostics market accounted for 38.49% of the global market in 2023. The industry is expected to keep expanding at lucrative growth during the forecast period with favorable & flexible regulatory framework. Presence of major manufacturers offering new IVD products, more testing and focus on disease management are the major factors driving the North America region. For example, in August 2023, the FDA provided a BD Vaginal Panel in the BD COR program to identify infectious agents that cause vaginal infections. The market for infectious diseases in the United States is expected to grow during the forecast period. The outbreak of COVID-19 dramatically changed the market landscape of diagnostics as companies engaged in test development with faster and more efficient turnaround times.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Infectious Disease Diagnostics Market Competitive Landscape

Infectious Disease Diagnostics Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Infectious Disease Diagnostics Market Competitive Landscape

Infectious Disease Diagnostics Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Infectious Disease Diagnostics Market?

Who are the key vendors in the Infectious Disease Diagnostics Market?

What is the key driver of Infectious Disease Diagnostics Market?

What is the key market trend for Infectious Disease Diagnostics Market?

Which region accounted for the largest share in Infectious Disease Diagnostics Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300